HIV-related costs in public hospital settings: Impact of HAART

Infectious Diseases in Clinical Practice

Volumn 10, Issue SUPPL. 1, 2001, Pages

  Keiser, P ^a  

^a Parkland HIV AIDS Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; TREATMENT OUTCOME; UNITED STATES;

EID: 0034840077     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200103001-00005     Document Type: Conference Paper

References (1)

1. Protease inhibitor-based therapy is associated with decrease HIV-related health care costs in men treated at a Veterans Administration hospital